Multiple sclerosis (MS) is an unpredictable disease of the nervous system that disrupts communication between the brain and other parts of the body. Its effects can range from relatively mild in most cases to somewhat disabling to devastating. The symptoms may mysteriously occur and then disappear. In the worst cases, a person with MS may be unable to write, speak, or walk. About 350,000 Americans have MS, with most cases occurring between 18 - 45 years of age.
During an MS attack, inflammation occurs in areas of the white matter (pale colored nerve tissue) of the central nervous system in random patches called plaques. This is followed by destruction of myelin, the fatty covering that protects nerve cell fibers in the brain and spinal cord. Myelin allows for the smooth, high speed transmission of electrochemical messages between the brain, the spinal cord, and the rest of the body. When myelin is damaged, neurological transmission of messages may be slowed or blocked completely, resulting in diminished or lost function.
The cause of MS is unknown, however, the disease is thought to be a T-cell autoimmune disease influenced by genetic and environmental factors. Other theories include a childhood virus that primes the immune system for an attack against myelin in early adulthood.
People with the following conditions or characteristics are at risk for developing MS:
If you or someone you care for is experiencing symptoms associated with MS, you should see your health care provider. Your health care provider will take a history of clinical symptoms, check for neurological problems, and refer you for lab tests, such as a cerebrospinal fluid exam and agar gel electrophoresis, and imaging procedures, such as a computed tomography scan (CT scan) and magnetic resonance imaging (MRI).
The primary goal of a treatment plan is to reduce the severity of attacks through the use of certain medications and to extend the individual's physical functioning for as long as possible.
Your health care provider may prescribe the following medications:
Surgery may be used to treat severe and disabling tremors or to reduce severe spasms.
A comprehensive treatment plan for MS may include a range of complementary and alternative therapies.
These nutritional tips may help reduce symptoms:
You may address nutritional deficiencies with the following supplements:
Herbs are generally a safe way to strengthen and tone the body's systems. As with any therapy, you should speak with your health care provider before starting any treatment. You may use herbs as dried extracts (capsules, powders, teas), glycerites (glycerine extracts), or tinctures (alcohol extracts). Unless otherwise indicated, make teas with 1 tsp. herb per cup of hot water. Steep covered 5 - 10 minutes for leaf or flowers, and 10 - 20 minutes for roots. Drink 2 - 4 cups per day. You may use tinctures alone or in combination as noted.
Although few studies have examined the effectiveness of specific homeopathic therapies, professional homeopaths may consider the following remedies for the treatment of gastritis symptoms (such as nausea and vomiting) based on their knowledge and experience. Before prescribing a remedy, homeopaths take into account your constitutional type -- your physical, emotional, and psychological makeup. An experienced homeopath assesses all of these factors when determining the most appropriate treatment for you individually. Combination remedies may be used for fatigue, spasm, and to help rid the body of impurities.
Acupuncture may alleviate symptoms. Acupuncture may help enhance immune function, normalize digestion, and address disease conditions. Scalp acupuncture may be particularly helpful and is used often with neurological complaints.
Massage is important for maintaining flexibility and reducing spasticity, as well as improving overall sense of well being.
About 70% of patients experience attacks and remissions, and about half of these undergo a chronic, progressive worsening after about 10 years. Between 10 - 15% of patients experience a chronic, progressive worsening of the disease from the initial onset, and 15 - 20% of patients have a relatively mild course of disease. Most MS patients live for 30 years or more, many still working and mobile, though bladder, bowel and sexual dysfunction are common among this population. Patients who have MS are at higher risk than the general population of developing bone loss from inactivity, steroid use, and vitamin D deficiency. MS is also associated with increased risk for some cancers, including urinary organs and brain tumors.
Patients need lifelong monitoring, especially during flare-ups.
Bahmanyar S, Montgomery SM, Hillert J, Ekbom A, Olsson T. Cancer risk among patients with multiple sclerosis. Neurology. 2009;72(13):1170-7.
Cabrera C, Artacho R, Gimenez R. Beneficial effects of green tea -- a review. J Am Coll Nutr. 2006;25(2):79-99.
Courtney A, Treadaway K, Remington G, Elliot F. Multiple Sclerosis. Medical Clinics of North America. 2009;93(2).
Cvetnic Z, Vladimir-Knezevic S. Antimicrobial activity of grapefruit seed and pulp ethanolic extract. Acta Pharm. 2004;54(3):243-50.
Das M, Sur P, Gomes A, Vedasiromoni JR, Ganguly DK. Inhibition of tumor growth and inflammation by consumption of tea. Phytother Res. 2002;16 Suppl 1:S40-4.
Dorchies OM, Wagner S, Vuadens O, et al. Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. Am J Physiol Cell Physiol. 2006;290(2):C616-25.
Farinotti M, Simi S, Di Pietrantonj C, et al. Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev. 2007;(1):CD004192.
Hale LP, Greer PK, Trinh CT, James CL. Proteinase activity and stability of natural bromelain preparations. Int Immunopharmacol. 2005;5(4):783-93.
Huntley A. A review of the evidence for efficacy of complementary and alternative medicines in MS. Int MS J. 2006 Jan;13(1):5-12, 4.
Johnson SK, Diamond BJ, Rausch S, et al. The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial. Explore (NY). 2006;2(1):19-24.
Kim SE. Daclizumab treatment for multiple sclerosis. Pharmacotherapy. 2009;29(2):227-35.
Kimball SM, Ursell MR, O'Connor P, Vieth R. Safety of vitamin D3 in adults with multiple sclerosis. soudnsm J Clin Nutr. 2007;86(3):645-51.
Kormosh N, Laktionov K, Antoshechkina M. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother Res. 2006;20(5):424-5.
Mark BL, Carson JA. Vitamin D and autoimmune disease -- implications for practice from the multiple sclerosis literature. J Am Diet Assoc. 2006;106(3):418-24.
[No authors listed]. L-theanine. Monograph. Altern Med Rev. 2005;10(2):136-8.
Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21(6):495-505.
Snook EM, Motl RW. Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis. Neurorehabil Neural Repair. 2009;23(2):108-116.
Whitmarsh TE. Homeopathy in multiple sclerosis. Complement Ther Nurs Midwifery. 2003;9(1):5-9.
Yoon JH, Baek SJ. Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med J. 2005;46(5):585-96.
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885